£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

COPD Treatment Outlook 2023-2028 - US Zip Code Analysis

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 31 days · 31 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 10 August 2026 18 August 2026 25 August 2026 02 September 2026
View at Amazon ↗

Price data last checked 60 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 31 days • 1 price levels

Days at Price
31 days 0 8 16 23 31 £490 Days at Price

Price Analysis

Most common price: £490 (31 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 31 days

Description

This detailed study provides a comprehensive outlook for chronic obstructive pulmonary disease (COPD) treatments across the United States from 2023 to 2028. The report focuses on latent demand, expressed in millions of U.S. dollars, also referred to as potential industry earnings (P.I.E.). By analyzing data across 10,833 individual zip codes, this research offers a granular view of market opportunities. Users can access comparative benchmarks that report the percent share of each zip code relative to its specific state and the United States as a whole. This statistical approach allows for quick assessment of specific locations against broader regional and national trends. This data is designed to assist with distribution planning and sales strategies by identifying high-potential areas for COPD treatment products.

Key Features

Provides latent demand estimates in millions of U.S. dollars for COPD treatments through 2028.

Includes potential industry earnings (P.I.E.) data across 10,833 specific US zip codes.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state.

Allows for quick gauging of individual zip code performance against the United States as a whole.

Supports distribution and sales strategy development through detailed geographic statistical analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 28 Aug 2026
The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India
98% match

The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India

£495.00 19 Aug 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes

£490.00 27 Aug 2026
US Respiratory Disorder Treatment Outlook 2023-2028 Study
98% match

US Respiratory Disorder Treatment Outlook 2023-2028 Study

£490.00 25 Aug 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China

£495.00 28 Aug 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan

£495.00 02 Sep 2026
The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics
97% match

The 2016-2021 World Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics

£995.00 29 Oct 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
97% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis Treatments

Price unavailable
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
97% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China

£495.00 20 Aug 2026
The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis
97% match

The 2023-2028 World Outlook for Idiopathic Pulmonary Fibrosis

Price unavailable
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
97% match

The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments

£790.00 20 Aug 2026
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
97% match

Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
97% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan

£495.00 02 Sep 2026
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis
97% match

The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis

£790.00 19 Aug 2026
The 2023-2028 Outlook for Respiratory Disorder Treatments in China
97% match

The 2023-2028 Outlook for Respiratory Disorder Treatments in China

£495.00 20 Aug 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
97% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States

£520.00 20 Aug 2026
Chronic Obstructive Pulmonary Disease - Contemporary and Consummate Management of a Systemic Disorder
97% match

Chronic Obstructive Pulmonary Disease - Contemporary and Consummate Management of a Systemic Disorder

IntechOpen

£114.00 23 Sep 2026
Chronic Obstructive Pulmonary Disease: Current Concepts and Practice
97% match

Chronic Obstructive Pulmonary Disease: Current Concepts and Practice

IntechOpen

£139.00 09 Oct 2026
The 2023-2028 Outlook for Respiratory Disorder Treatments in Japan
97% match

The 2023-2028 Outlook for Respiratory Disorder Treatments in Japan

£495.00 30 Oct 2026
The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments
97% match

The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments

Price unavailable
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
97% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
Asthma Treatment Outlook 2023-2028 - US Zip Code Study
97% match

Asthma Treatment Outlook 2023-2028 - US Zip Code Study

£490.00 02 Sep 2026
Chronic Obstructive Pulmonary Disease: A Current Conspectus
97% match

Chronic Obstructive Pulmonary Disease: A Current Conspectus

IntechOpen

£114.00 18 Sep 2026